Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

Pasireotide G2304 Study Group, for the, Pasireotide G2304 Study Group

Research output: Contribution to journalArticlepeer-review

112 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences